Amivantamab, a bispecific epidermal growth factor receptor and mesenchymal-epithelial transition factor inhibitor, associated with ulcerative intertrigo.
Publication
, Journal Article
Concannon, HR; Ku, RG; Brazel, M; Selim, MA; Fresco, A
Published in: JAAD Case Rep
December 2025
Duke Scholars
Published In
JAAD Case Rep
DOI
ISSN
2352-5126
Publication Date
December 2025
Volume
66
Start / End Page
12 / 14
Location
United States
Related Subject Headings
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Concannon, H. R., Ku, R. G., Brazel, M., Selim, M. A., & Fresco, A. (2025). Amivantamab, a bispecific epidermal growth factor receptor and mesenchymal-epithelial transition factor inhibitor, associated with ulcerative intertrigo. JAAD Case Rep, 66, 12–14. https://doi.org/10.1016/j.jdcr.2025.08.035
Concannon, Hannah R., Robyn G. Ku, Morgan Brazel, Maria Angelica Selim, and Amber Fresco. “Amivantamab, a bispecific epidermal growth factor receptor and mesenchymal-epithelial transition factor inhibitor, associated with ulcerative intertrigo.” JAAD Case Rep 66 (December 2025): 12–14. https://doi.org/10.1016/j.jdcr.2025.08.035.
Concannon HR, Ku RG, Brazel M, Selim MA, Fresco A. Amivantamab, a bispecific epidermal growth factor receptor and mesenchymal-epithelial transition factor inhibitor, associated with ulcerative intertrigo. JAAD Case Rep. 2025 Dec;66:12–4.
Concannon, Hannah R., et al. “Amivantamab, a bispecific epidermal growth factor receptor and mesenchymal-epithelial transition factor inhibitor, associated with ulcerative intertrigo.” JAAD Case Rep, vol. 66, Dec. 2025, pp. 12–14. Pubmed, doi:10.1016/j.jdcr.2025.08.035.
Concannon HR, Ku RG, Brazel M, Selim MA, Fresco A. Amivantamab, a bispecific epidermal growth factor receptor and mesenchymal-epithelial transition factor inhibitor, associated with ulcerative intertrigo. JAAD Case Rep. 2025 Dec;66:12–14.
Published In
JAAD Case Rep
DOI
ISSN
2352-5126
Publication Date
December 2025
Volume
66
Start / End Page
12 / 14
Location
United States
Related Subject Headings
- 3202 Clinical sciences